Updated French guidelines for the therapeutic management of bullous pemphigoid - 01/06/22

Doi : 10.1016/j.annder.2021.08.005

M. Castel ^a,^h,^⁎ , M. Alexandre ^b, L. Jelti ^a, A. Pham-Ledard ^c, M. Viguier ^d, C. Bédane ^e, E. Tancrède-Bohin ^f, P. Musette ^b, P. Carvalho ^a, N. Cordel ^g,^h, F. Caux ^b, P. Joly ^a,^h
the
French Study Group on Autoimmune Bullous Skin Diseases^¹
The following members of the French study group on AIBD also participated in the preparation of the French BP guidelines and reviewed the manuscript: G. Quereux, S.Debarbieux, S. Ingen-Housz-Oro, O. Dereure, S. Duvert-Lehembre, G. Chaby, C. Le Roux-Villet, M.-P. Konstantinou, J.-D. Bouaziz, C. Lok, I. Bourgault-Villada, E. Le Bidre, B. Sassolas, M. D’Incan, N. Dupin, C. Prost, C. Picard-Dahan, M-S. Doutre, C. Abasq, M.-A. Richard, G. Jeudy, F. Lombart.
^a Department of Dermatology, Rouen University Hospital, University of Normandy, 76000 Rouen, France
^b Department of Dermatology, University of Paris XIII, 93000 Bobigny, France
^c Department of Dermatology, University of Bordeaux, 33000 Bordeaux, France
^d Department of Dermatology, University of Reims, 51100 Reims, France
^e Department of Dermatology, University of Limoges, 87000 Limoges, France
^f Department of Dermatology, University of Paris X, 75010 Paris, France
^g Department of Dermatology and Clinical Immunology, Guadeloupe University Hospital, Point-à-Pitre, Guadeloupe
^h Institut National de la Santé et de la Recherche Médicale U1234, Centre de Référence des Maladies Bulleuses Autoimmunes, University of Normandy, 76000 Rouen, France

^⁎Corresponding author.